PD-L1 expression was described in many tumors and their microenvironments [51,60,61,62,77] and is a main component of the tumor’s armamentarium to prevent immune destruction by inhibition of activation, expansion, and effector functions of T-cells [75,78,79]. The gene discussed is CD274; the disease is neoplasm.